S&P 500   5,111.16 (+0.29%)
DOW   39,008.40 (+0.03%)
QQQ   442.19 (+0.73%)
AAPL   179.09 (-0.92%)
MSFT   412.77 (-0.21%)
META   499.88 (+1.99%)
GOOGL   137.87 (-0.43%)
AMZN   177.38 (+0.35%)
TSLA   200.43 (-0.72%)
NVDA   808.13 (+2.15%)
NIO   5.76 (+0.17%)
AMD   201.38 (+4.60%)
BABA   74.56 (+0.72%)
T   16.96 (+0.18%)
F   12.56 (+0.96%)
MU   94.86 (+4.69%)
CGC   3.17 (-3.65%)
GE   158.69 (+1.15%)
DIS   111.92 (+0.30%)
AMC   4.35 (+0.69%)
PFE   26.59 (+0.11%)
PYPL   61.43 (+1.81%)
XOM   105.56 (+1.00%)
S&P 500   5,111.16 (+0.29%)
DOW   39,008.40 (+0.03%)
QQQ   442.19 (+0.73%)
AAPL   179.09 (-0.92%)
MSFT   412.77 (-0.21%)
META   499.88 (+1.99%)
GOOGL   137.87 (-0.43%)
AMZN   177.38 (+0.35%)
TSLA   200.43 (-0.72%)
NVDA   808.13 (+2.15%)
NIO   5.76 (+0.17%)
AMD   201.38 (+4.60%)
BABA   74.56 (+0.72%)
T   16.96 (+0.18%)
F   12.56 (+0.96%)
MU   94.86 (+4.69%)
CGC   3.17 (-3.65%)
GE   158.69 (+1.15%)
DIS   111.92 (+0.30%)
AMC   4.35 (+0.69%)
PFE   26.59 (+0.11%)
PYPL   61.43 (+1.81%)
XOM   105.56 (+1.00%)
S&P 500   5,111.16 (+0.29%)
DOW   39,008.40 (+0.03%)
QQQ   442.19 (+0.73%)
AAPL   179.09 (-0.92%)
MSFT   412.77 (-0.21%)
META   499.88 (+1.99%)
GOOGL   137.87 (-0.43%)
AMZN   177.38 (+0.35%)
TSLA   200.43 (-0.72%)
NVDA   808.13 (+2.15%)
NIO   5.76 (+0.17%)
AMD   201.38 (+4.60%)
BABA   74.56 (+0.72%)
T   16.96 (+0.18%)
F   12.56 (+0.96%)
MU   94.86 (+4.69%)
CGC   3.17 (-3.65%)
GE   158.69 (+1.15%)
DIS   111.92 (+0.30%)
AMC   4.35 (+0.69%)
PFE   26.59 (+0.11%)
PYPL   61.43 (+1.81%)
XOM   105.56 (+1.00%)
S&P 500   5,111.16 (+0.29%)
DOW   39,008.40 (+0.03%)
QQQ   442.19 (+0.73%)
AAPL   179.09 (-0.92%)
MSFT   412.77 (-0.21%)
META   499.88 (+1.99%)
GOOGL   137.87 (-0.43%)
AMZN   177.38 (+0.35%)
TSLA   200.43 (-0.72%)
NVDA   808.13 (+2.15%)
NIO   5.76 (+0.17%)
AMD   201.38 (+4.60%)
BABA   74.56 (+0.72%)
T   16.96 (+0.18%)
F   12.56 (+0.96%)
MU   94.86 (+4.69%)
CGC   3.17 (-3.65%)
GE   158.69 (+1.15%)
DIS   111.92 (+0.30%)
AMC   4.35 (+0.69%)
PFE   26.59 (+0.11%)
PYPL   61.43 (+1.81%)
XOM   105.56 (+1.00%)

ONE Bio (ONBI) News Today

$0.0030
0.00 (0.00%)
(As of 02/29/2024 ET)
SourceHeadline
markets.businessinsider.com logoBuy Rating Affirmed for Day One Biopharmaceuticals Amid Strong Pre-Launch Strategy and Solid Financials
markets.businessinsider.com - February 27 at 4:20 PM
msn.com logoINmune Bio (INMB) Price Target Increased by 13.46% to 20.06
msn.com - February 25 at 1:13 AM
msn.com logoIntelligent Bio Solutions (INBS) Price Target Increased by 1100.00% to 113.83
msn.com - February 24 at 10:08 AM
markets.businessinsider.com logoOne Big Step for Bioelectronic Implant Developers Including US Nuclear’s Partner Grapheton
markets.businessinsider.com - February 12 at 1:22 PM
msn.com logoBelfast bio-tech firm using AI to help cure cancer, awarded £1.4m in grant funding
msn.com - February 12 at 8:21 AM
bizjournals.com logoStartups to Watch: Mercury Bio ready to scale biomolecular drug delivery platform
bizjournals.com - February 6 at 10:00 PM
msn.com logoUPDATE 2-2seventy bio to sell experimental cell therapies, names new CEO
msn.com - January 31 at 9:03 AM
msn.com logoThis Biotech Company Could Change the IVF Process for People Like Me With Low Ovarian Reserve
msn.com - January 23 at 12:06 AM
msn.com logoIn 2024, Biosensors Are Becoming More Accessible: What It Means for You
msn.com - January 21 at 1:27 PM
msn.com logoIf You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
msn.com - January 10 at 6:59 PM
msn.com logoProcept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest'
msn.com - January 9 at 2:32 PM
axios.com logoImbed Biosciences unwraps $10M convertible financing
axios.com - January 8 at 9:10 AM
msn.com logoBayer-AskBio’s Parkinson’s gene therapy trial meets primary endpoint
msn.com - January 5 at 3:10 PM
bizjournals.com logoPeninsula biotech raises $95 million to target diseases wreaking havoc on the immune system
bizjournals.com - January 5 at 10:09 AM
au.finance.yahoo.com logoONE Bio Corp. (ONBI)
au.finance.yahoo.com - December 28 at 8:10 PM
msn.com logoBIO-key repays $2.2M senior secured note
msn.com - December 21 at 9:36 AM
marketwatch.com logoINmune Bio Shares Drop as Alzheimer's Treatment Study Remains on Hold
marketwatch.com - December 19 at 6:42 AM
msn.com logoBluebird bio, Rockwell Medical among healthcare movers
msn.com - December 8 at 1:18 PM
msn.com logoAbbVie to Buy Neuroscience Biotech Firm Cerevel for $8.7 Billion
msn.com - December 6 at 7:40 PM
yahoo.com logoOctarine Bio Raises $4.6M to Scale Bio-Based Dyes
yahoo.com - December 4 at 7:17 PM
seekingalpha.com logoBioVie: Update Following Topline Results (Rating Downgrade)
seekingalpha.com - December 2 at 4:00 AM
yahoo.com logoMeet ‘anthrobots,’ tiny bio-machines built from human tracheal cells
yahoo.com - November 30 at 9:12 PM
bizjournals.com logoAnnovis Bio stock price jumps on positive news about experimental Alzheimer's disease therapy
bizjournals.com - November 27 at 4:53 PM
markets.businessinsider.com logoViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
markets.businessinsider.com - November 13 at 9:14 AM
msn.com logoDeep Bio and CancerX bring AI to cancer diagnostics and prognosis
msn.com - November 8 at 7:41 PM
msn.com logoKorean gov’t launches Bio-Health Innovation Commission to support AI and nanotech growth
msn.com - November 6 at 3:32 AM
benzinga.com logoBIO-key International Announces Closing of $3.75 Million Public Offering
benzinga.com - October 31 at 5:33 PM
msn.com logoBIO-key International announces pricing of $3.75M public offering
msn.com - October 30 at 8:04 PM
benzinga.com logoBIO-key International Announces Pricing of $3.75 Million Public Offering
benzinga.com - October 30 at 3:04 PM
benzinga.com logoIntelligent Bio (NASDAQ: INBS) Announces New Zealand Expansion: Medical Stocks Growing Momentum" INBS, XTRX, CNXA, DNA
benzinga.com - October 24 at 6:47 PM
marketwatch.com logoGeneration Bio Shares Fall to 52-Week Low After DNA Update
marketwatch.com - October 19 at 2:11 PM
techcrunch.com logoIsraeli biotech startup mana.bio launches AI-fueled programmable drug therapy
techcrunch.com - October 12 at 9:15 PM
bizjournals.com logo2seventy bio CEO out as company lays off 176
bizjournals.com - September 12 at 3:44 PM
msn.com logoRBC Capital Maintains Avid Bioservices (CDMO) Outperform Recommendation
msn.com - September 9 at 2:17 AM
bizjournals.com logoHow BioFlyte's bioaerosol technology works
bizjournals.com - September 6 at 12:07 AM
yahoo.com logoBiotech Company Says It's Implanted Dopamine-Making Cells in Patients' Brains
yahoo.com - September 4 at 6:28 PM
msn.com logoThe Danger of ‘Invisible’ Biolabs Across the U.S.
msn.com - August 31 at 7:25 PM
msn.com logoDown -26.93% in 4 Weeks, Here's Why BioVie Inc. (BIVI) Looks Ripe for a Turnaround
msn.com - August 30 at 4:33 PM
bizjournals.com logoCuri Bio lands over $4.4M in NIH grants for two projects
bizjournals.com - August 24 at 8:42 PM
technews.tmcnet.com logoIdentity and Access Management Provider BIO-key Reports Q2 Revenue of $1.9M; Hosts Investor Call Tomorrow, August 15th at 10am ET
technews.tmcnet.com - August 14 at 6:28 PM
msn.com logoWhy Ginkgo Bioworks Stock Plunged by 8% This Week
msn.com - August 11 at 10:08 PM
msn.com logoGinkgo Bioworks preps early-warning systems for next pandemic
msn.com - August 10 at 2:34 PM
msn.com logoTD Cowen Maintains Biolife Solutions (BLFS) Outperform Recommendation
msn.com - August 10 at 9:34 AM
benzinga.com logoFDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
benzinga.com - August 8 at 4:22 AM
msn.com logoConcord Biotech IPO subscribed 1.6 times on the second day so far
msn.com - August 7 at 8:44 AM
msn.com logoAvroBio (AVRO) Price Target Increased by 6.05% to 3.88
msn.com - August 2 at 5:27 AM
msn.com logoINVO Bioscience (INVO) Price Target Increased by 1900.00% to 20.40
msn.com - August 2 at 5:27 AM
bizjournals.com logoCambridge biotech Ribon cuts employees, halts preclinical work
bizjournals.com - July 31 at 7:49 AM
bizjournals.com logoIt's not the big biotech convention, but a high-profile industry event is returning to San Francisco
bizjournals.com - July 29 at 7:28 AM
marketwatch.com logoAdicet Bio Down 54% After Reporting Data From Non-Hodgkin's Lymphoma Study
marketwatch.com - June 28 at 9:42 AM
Get ONE Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONBI and its competitors with MarketBeat's FREE daily newsletter.



ONBI Media Mentions By Week

ONBI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONBI
News Sentiment

0.52

0.31

Average
Basic Materials
News Sentiment

ONBI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONBI Articles
This Week

3

1

ONBI Articles
Average Week

Get ONE Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONBI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:ONBI) was last updated on 3/1/2024 by MarketBeat.com Staff